HUMACYTE INC (HUMA) Stock Income Statement
NASDAQ:HUMA - Nasdaq - US44486Q1031 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 517.00K | 0.00 | 0.00 | 1.57M | 1.26M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | 180.00K | |||
| Gross Profit | N/A | N/A | N/A | N/A | 1.09M | |||
| Operating Expenses | 111.29M | 114.00M | 100.05M | 86.14M | 82.47M | |||
| Research and Development | N/A | N/A | 76.55M | 63.26M | 61.34M | |||
| Selling, General, and Administrative Expenses | 28.62M | 26.00M | 23.50M | 22.88M | 21.13M | |||
| Operating Income | -110.92M | -114.00M | -100.05M | -84.58M | -81.20M | |||
| Interest Income/Expense | N/A | N/A | -1.39M | -3.57M | -4.33M | |||
| Other Income/Expense | 21.28M | -33.00M | -10.02M | 76.18M | 55.78M | |||
| Non Recurring Items | N/A | 0.00 | 686.00K | 0.00 | 3.28M | |||
| Income Before Taxes | -77.73M | -149.00M | -110.78M | -11.97M | -26.48M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -77.73M | -149.00M | -110.78M | -11.97M | -26.48M | |||
| EBITDA | -103.68M | -106.81M | -92.33M | -76.37M | -72.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.67 | -1.26 | -1.07 | -0.12 | -0.26 | |||
| Non GAAP EPS | -0.69 | -1.26 | -1.07 | -0.13 | -0.51 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | 86.51% | |||
| Profit Margin | -15034.04% | N/A | N/A | -762.42% | -2101.59% | |||
| Operating Profit Margin | -21453.77% | N/A | N/A | -5387.26% | -6444.44% | |||
All data in USD